Gerresheimer Ag · XETR:GXI
Gerresheimer — Investor Day (October 2008)
27 slides from Gerresheimer's investor day presentation, Oct 23, 2008
Slide 1: Close-up Medical Plastic Systems
Close-up Medical Plastic Systems Gerresheimer Capital Markets Day October 23+24, 2008 Dr. Axel Herberg, CEO 0
Slide 2: Disclaimer
Disclaimer This presentation may contain certain forward-looking statements, including assumptions, opinions and views of the Company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or
Slide 3: Gerresheimer at a glance
Gerresheimer at a glance 2007 Sales in EUR m Tubular Glass Plastic Systems Moulded Glass Life Science (Plastic Drug Delivery and (Injectable Glass and Systems) Systems) Research Net sales: EUR 271m Net sales: EUR 300m Net sales: EUR 319m EUR 72m Adj. EBITDA margin: 24.6% Adj. EBITDA margin: 18.7% Ad
Slide 4: Overview Plastic Systems
Overview Plastic Systems Plastic Systems Net Sales: EUR 300m Plastic Packaging GX Wilden Medical Plastic Technical Plastic Systems (MPS) Systems (TPS) Products Standard Customized Plants 8 8 Employees 937 2,224 Note: Employees figures as of August 31, 2008 3
Slide 5: Global plant portfolio Plastic Systems (ex. TPS)
Global plant portfolio Plastic Systems (ex. TPS) Vaerloese, Horšovský Týn, Denmark Czech Republic Boleslawiec, Haarby, Pfreimd, Poland Denmark Germany (PS) Peachtree Dongguan, City, GA, US China (Joint venture) Regensburg TCC1, Valencia, Sao Paulo, (Admin/ sales), Wackersdorf, Spain Brasil Germany G
Slide 6: Medical Plastic Systems is composed of two product areas
Medical Plastic Systems is composed of two product areas Medical Plastic Systems Pharma Diagnostics Inhalation Diabetes Care Injection Laboratory & Molecular Pens Other Diagnostics 5
Slide 7: Gerresheimer Wilden Pharma: Pulmonary Inhalation
Gerresheimer Wilden Pharma: Pulmonary Inhalation - Turbuhaler (AstraZeneca): Multidose-Dry-Powder-Inhaler - 6
Slide 8: Gerresheimer Wilden Pharma: Pulmonary Inhalation
Gerresheimer Wilden Pharma: Pulmonary Inhalation - Novolizer (Almirall): Multidose-Dry-Powder-Inhaler - 7
Slide 9: Gerresheimer Wilden Pharma: Pulmonary Inhalation
Gerresheimer Wilden Pharma: Pulmonary Inhalation - Respimat® Soft Inhaler (Boehringer Ingelheim): Active Dosing Aerosol without Propellant - 8
Slide 10: Gerresheimer Wilden Pharma: Pulmonary Inhalation
Gerresheimer Wilden Pharma: Pulmonary Inhalation - HandiHaler® (Boehringer Ingelheim): Inhaler for the treatment of COPD (chronic-obstructive bronchitis) - 9
Slide 11: Gerresheimer Wilden Pharma: Injection
Gerresheimer Wilden Pharma: Injection - Tamper Evident Seals for Syringe Systems - 10
Slide 12: Injection – Insulin pen (Novo Nordisk)
Gerresheimer Wilden Pharma: Injection – Insulin pen (Novo Nordisk) 11
Slide 13: Gerresheimer Wilden Pharma: Diabetes Diagnostics
Gerresheimer Wilden Pharma: Diabetes Diagnostics - ACCU-CHEK® Softclix (Roche Diagnostics): Lancing Device - 12
Slide 14: Gerresheimer Wilden Pharma: Diabetes Diagnostics
Gerresheimer Wilden Pharma: Diabetes Diagnostics -ACCU-CHEK® Multiclix (Roche Diagnostics): -Lancing Device with 6-lancet-drum - 13
Slide 15: Gerresheimer Wilden Pharma: Diabetes Diagnostics
Gerresheimer Wilden Pharma: Diabetes Diagnostics - Lancets for Lancing Devices (Roche Diagnostics) - 14
Slide 16: Gerresheimer Wilden Pharma: Laboratory Diagnostics
Gerresheimer Wilden Pharma: Laboratory Diagnostics - Cuvettes (Roche Diagnostics) - 15
Slide 17: Growth drivers Gerresheimer Wilden Medical Plastic Systems
Growth drivers Gerresheimer Wilden Medical Plastic Systems New devices Growth from outsourcing Examples: Innovative inhaler systems Base Base growth growth Examples: Safety device for Pen production injection Benefit from growth of relevant Assembly of filled Infusion devices markets product into a
Slide 18: Business model Medical Plastic Systems
Business model Medical Plastic Systems Engineering (TCC) Production Product and Moldmaking Automation Production Assembly / Logistics - just-in- procedure develop- Engineering Packaging time ment, manufacturing equipment construction Sales Tools and assembly line Parts Success Engineering know-how;
Slide 19: Technical Competence Center (TCC) – Location Wackersdorf, Germany
Technical Competence Center (TCC) – Location Wackersdorf, Germany Concentration of technological expertise at one location Engineering of new products together with the customer Enforcement of worldwide uniform production standards Material and pharmaceutical laboratory, measuring room with product-
Slide 20: Production facilities Medical Plastic Systems
Production facilities Medical Plastic Systems Pfreimd, GERMANY Kuessnacht, SWITZERLAND Horšovský Týn, CZECH REPUBLIC Dongguan City, close to Peachtree City, close to Atlanta Hongkong CHINA USA 19
Slide 21: Location Pfreimd, Germany
Location Pfreimd, Germany Production area 10,200 m2 ―of that, clean room area: 6,300 m2 that, controlled area: 3,400 m2 Key products: Inhalers, diagnostic devices Production strategy ―Highly automated assembly process; high volume series ―Start-up production facility for new products and processes ―
Slide 22: Location Kuessnacht, Switzerland
Location Kuessnacht, Switzerland Production area 3,500 m2 ―of that, clean room area: 2,300 m2 ―of that, controlled area: 800 m2 Key products: Cuvettes Production strategy ―Highly automated processes in line with high output injection molding ―Competence in reaction vessels and cuvettes 21
Slide 23: Location Horšovský Týn, Czech Republic
Location Horšovský Týn, Czech Republic Production area 4,903 m2 ―of that, clean room area: 1,596 m2 ―of that, controlled area: 2,840 m2 Key products: Pens and Inhalers Production strategy Manual, semi-automated and highly automated assembly process; injection molding low to high volume series 22
Slide 24: Location Peachtree City, USA
Location Peachtree City, USA Production area 3,000 m2 ―of that, clean room area: 800 m2 ―of that, controlled area: 800 m2 Key product: Inhalers Production strategy ―Highly automated assembly processes; medium to high volume series ―Highly automated injection molding process Ramp-up of inhaler produc
Slide 25: Location Dongguan City, China
Location Dongguan City, China Production area 1,710 m2 ―of that, clean room area: 630 m2 ―of that, controlled area: 900 m2 Production strategy Mainly manual and semi-manual assembly processes Platform for future growth in China/Asia 24
Slide 26: Key criteria for successful manufacturing of drug delivery devices
Key criteria for successful manufacturing of drug delivery devices Track Track record record of of successful successful pharma pharma production production Regulatory Regulatory experience experience Excellent Excellent knowledge knowledge in in injection injection molding molding and and assembly
Slide 27: Medical Plastic Systems – A one-stop shop
Medical Plastic Systems – A one-stop shop Engineering (TCC) Production Product and Moldmaking Automation Production Assembly / Logistics - just-in- procedure develop- Engineering Packaging time ment, manufacturing equipment construction 26